What is it about?
We show in a prospective 5-year study of people with type 2 diabetes and mild retinopathy, the predictive value of ocular and systemic risk markers for the development of vision threatening complications. The observations here reported offer promising perspectives for personalized management of Diabetic Retinopathy
Featured Image
Read the Original
This page is a summary of: Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study, Diabetes Care, November 2020, American Diabetes Association,
DOI: 10.2337/dc20-1125.
You can read the full text:
Contributors
The following have contributed to this page







